SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-19-021718
Filing Date
2019-12-02
Accepted
2019-11-29 17:56:42
Documents
2
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. INC.KKR BIOSIMILAR GP LLCKKR BIOSIMILAR L.P.KKR FUND HOLDINGS GP LTDKKR GROUP HOLDINGS CORP.KKR MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 339572
2 EXHIBIT 99.G ex99_g.htm EX-99.G 49511
  Complete submission text file 0001140361-19-021718.txt   391034
Mailing Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-230-9742
KKR Fund Holdings L.P. (Filed by) CIK: 0001472698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88402 | Film No.: 191261775
SIC: 2836 Biological Products, (No Diagnostic Substances)